Want to join the conversation?
$CRM's marketing and sales costs of its total revenues for 3Q16 fell to 48% from 52%. $CRM expects marketing and sales costs still to represent substantial portion of revenues in future as it seeks to grow customer base, sell more products to existing customers, and build greater brand awareness.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?